IBDEI0P9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11803,2)
 ;;=^5019173
 ;;^UTILITY(U,$J,358.3,11804,0)
 ;;=R04.2^^47^536^25
 ;;^UTILITY(U,$J,358.3,11804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11804,1,3,0)
 ;;=3^Hemoptysis
 ;;^UTILITY(U,$J,358.3,11804,1,4,0)
 ;;=4^R04.2
 ;;^UTILITY(U,$J,358.3,11804,2)
 ;;=^5019175
 ;;^UTILITY(U,$J,358.3,11805,0)
 ;;=R04.9^^47^536^26
 ;;^UTILITY(U,$J,358.3,11805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11805,1,3,0)
 ;;=3^Hemorrhage from Respiratory Passages,Unspec
 ;;^UTILITY(U,$J,358.3,11805,1,4,0)
 ;;=4^R04.9
 ;;^UTILITY(U,$J,358.3,11805,2)
 ;;=^5019178
 ;;^UTILITY(U,$J,358.3,11806,0)
 ;;=R09.02^^47^536^27
 ;;^UTILITY(U,$J,358.3,11806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11806,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,11806,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,11806,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,11807,0)
 ;;=J11.2^^47^536^28
 ;;^UTILITY(U,$J,358.3,11807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11807,1,3,0)
 ;;=3^Influenza w/ GI Manifestation
 ;;^UTILITY(U,$J,358.3,11807,1,4,0)
 ;;=4^J11.2
 ;;^UTILITY(U,$J,358.3,11807,2)
 ;;=^5008159
 ;;^UTILITY(U,$J,358.3,11808,0)
 ;;=J11.89^^47^536^29
 ;;^UTILITY(U,$J,358.3,11808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11808,1,3,0)
 ;;=3^Influenza w/ Other Manifestation
 ;;^UTILITY(U,$J,358.3,11808,1,4,0)
 ;;=4^J11.89
 ;;^UTILITY(U,$J,358.3,11808,2)
 ;;=^5008163
 ;;^UTILITY(U,$J,358.3,11809,0)
 ;;=J11.00^^47^536^30
 ;;^UTILITY(U,$J,358.3,11809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11809,1,3,0)
 ;;=3^Influenza w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,11809,1,4,0)
 ;;=4^J11.00
 ;;^UTILITY(U,$J,358.3,11809,2)
 ;;=^5008156
 ;;^UTILITY(U,$J,358.3,11810,0)
 ;;=J04.0^^47^536^31
 ;;^UTILITY(U,$J,358.3,11810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11810,1,3,0)
 ;;=3^Laryngitis,Acute
 ;;^UTILITY(U,$J,358.3,11810,1,4,0)
 ;;=4^J04.0
 ;;^UTILITY(U,$J,358.3,11810,2)
 ;;=^5008137
 ;;^UTILITY(U,$J,358.3,11811,0)
 ;;=J37.0^^47^536^32
 ;;^UTILITY(U,$J,358.3,11811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11811,1,3,0)
 ;;=3^Laryngitis,Chronic
 ;;^UTILITY(U,$J,358.3,11811,1,4,0)
 ;;=4^J37.0
 ;;^UTILITY(U,$J,358.3,11811,2)
 ;;=^269902
 ;;^UTILITY(U,$J,358.3,11812,0)
 ;;=R09.81^^47^536^33
 ;;^UTILITY(U,$J,358.3,11812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11812,1,3,0)
 ;;=3^Nasal Congestion
 ;;^UTILITY(U,$J,358.3,11812,1,4,0)
 ;;=4^R09.81
 ;;^UTILITY(U,$J,358.3,11812,2)
 ;;=^5019203
 ;;^UTILITY(U,$J,358.3,11813,0)
 ;;=J34.2^^47^536^34
 ;;^UTILITY(U,$J,358.3,11813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11813,1,3,0)
 ;;=3^Nasal Septum,Deviated
 ;;^UTILITY(U,$J,358.3,11813,1,4,0)
 ;;=4^J34.2
 ;;^UTILITY(U,$J,358.3,11813,2)
 ;;=^259087
 ;;^UTILITY(U,$J,358.3,11814,0)
 ;;=J34.3^^47^536^35
 ;;^UTILITY(U,$J,358.3,11814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11814,1,3,0)
 ;;=3^Nasal Turbinates,Hypertrophy
 ;;^UTILITY(U,$J,358.3,11814,1,4,0)
 ;;=4^J34.3
 ;;^UTILITY(U,$J,358.3,11814,2)
 ;;=^269909
 ;;^UTILITY(U,$J,358.3,11815,0)
 ;;=J00.^^47^536^36
 ;;^UTILITY(U,$J,358.3,11815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11815,1,3,0)
 ;;=3^Nasopharyngitis,Acute
 ;;^UTILITY(U,$J,358.3,11815,1,4,0)
 ;;=4^J00.
 ;;^UTILITY(U,$J,358.3,11815,2)
 ;;=^5008115
 ;;^UTILITY(U,$J,358.3,11816,0)
 ;;=J31.1^^47^536^37
 ;;^UTILITY(U,$J,358.3,11816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11816,1,3,0)
 ;;=3^Nasopharyngitis,Chronic
 ;;^UTILITY(U,$J,358.3,11816,1,4,0)
 ;;=4^J31.1
 ;;^UTILITY(U,$J,358.3,11816,2)
 ;;=^269888
 ;;^UTILITY(U,$J,358.3,11817,0)
 ;;=J34.9^^47^536^38
 ;;^UTILITY(U,$J,358.3,11817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11817,1,3,0)
 ;;=3^Nose & Nasal Sinuse Disorder,Unspec
